Back to top

New Strong Buy Stocks for August 24th

Read MoreHide Full Article

Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today:

ARC Document Solutions, Inc. (ARC - Free Report) : This reprographics company has seen the Zacks Consensus Estimate for its current year earnings increasing 16.7% over the last 60 days.

ARC Document Solutions, Inc. Price and Consensus

 

ARC Document Solutions, Inc. Price and Consensus

ARC Document Solutions, Inc. price-consensus-chart | ARC Document Solutions, Inc. Quote

FGL Holdings (FG - Free Report) : This company that sells individual life insurance products and annuities has seen the Zacks Consensus Estimate for its current year earnings increasing 3.7% over the last 60 days.

FGL Holdings Price and Consensus

 

FGL Holdings Price and Consensus

FGL Holdings price-consensus-chart | FGL Holdings Quote

Hanger, Inc. (HNGR - Free Report) : This company that provides orthotic and prosthetic (O&P) services has seen the Zacks Consensus Estimate for its current year earnings increasing 6.5% over the last 60 days.

Hanger Inc. Price and Consensus

 

Hanger Inc. Price and Consensus

Hanger Inc. price-consensus-chart | Hanger Inc. Quote

HCA Healthcare, Inc. (HCA - Free Report) : This provider of health care services has seen the Zacks Consensus Estimate for its current year earnings increasing 4.5% over the last 60 days.North American Construction Group Ltd. (NOA - Free Report) : This company that provides heavy construction and mining services has seen the Zacks Consensus Estimate for its current year earnings increasing 84% over the last 60 days.

North American Construction Group Ltd. Price and Consensus

 

North American Construction Group Ltd. Price and Consensus

North American Construction Group Ltd. price-consensus-chart | North American Construction Group Ltd. Quote

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here

5 Medical Stocks to Buy Now

Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.

New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.

Click here to see the 5 stocks >>



More from Zacks Zacks #1 Rank Additions

You May Like